ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Ticker Update

Updates

SUB-TYPE:

26.11.2021

Christmas and New Year 2021/22 Bank Holiday Opening Hours now available

 

To help keep our customers informed of changes to our service, we have published our Christmas and New Year 2021/22 Bank Holiday opening hours.

 

Please click here for more information.

SUB-TYPE:

22.11.2021

Alphega Pharmacy Members Take Home Much Deserved Trophies at the C+D Awards for Outstanding Support They Bring to Community Pharmacy

 

The prestigious Chemist and Druggist Awards finally returned last week to a face-to-face ceremony at the Intercontinental Hotel in London, to recognise and celebrate the very best in the pharmacy industry. We are so delighted for three of our Alphega Pharmacy members who took home well-deserved Awards last Friday, for their outstanding work and vital support they bring to community pharmacy.

 

Congratulations to Lewis Pharmacy, Exmouth who walked away with the Training and Development Award, for the innovative Let’s Communicate Cancer programme, an e-learning portal to help equip pharmacy professionals with the tools and confidence to help patients on their cancer journey. The team also received a high commendation in the Independent Pharmacy of the Year category.

 

Dr Jackie Lewis had the following to say on this triumphant achievement: “It’s amazing to win an award and be recognised for all the hard work we put in. After a few difficult years in pharmacy and the current climate to also come out as highly commended in Independent Pharmacy of the Year on top of this is such a morale boost to the team and to share this with them is incredible.  To win the Training and Development award I am blown away. This win is going to be amazing for the publicity of this programme as we are looking at up-skilling the whole of community pharmacy with it. This programme will assist them with the early diagnosis of cancer to help their cancer patients and ensure they get the help they need.”

 

The ‘Let’s Communicate Cancer’ programme is an engaging e-learning portal for community pharmacy professionals, giving them access to real life case studies, slide shows, bit-sized quizzes and animations in order to give an entire pharmacy team the confidence, skills and knowledge to better help a cancer patients’ journey – from early diagnosis all the way through to treatment. 

 

Mandeep Mudhar, Head of Alphega Pharmacy UK had the following to say on the recent win: “I’m delighted to see Lewis Pharmacy recognised twice at the C+D awards. Jackie works tirelessly to champion the support and expertise community pharmacists can give to their patients and carers dealing with cancer, and this is on top of the numerous pharmacy services that Lewis Pharmacy offers – the consultation room in Lewis Pharmacy is never quiet!  A massive congratulations to Jackie and the whole team at Lewis Pharmacy.”

 

The E-learning module for the Let’s Communicate Cancer Programme can be accessed by pharmacy teams at https://www.bopa.org.uk/cancer-elearning-for-community-pharmacy-lets-communicate-cancer/.

 

A further congratulations goes to two fantastic Alphega Pharmacy members, firstly James Tibbs, AR Pharmacy for picking up the Community Pharmacist of the Year Award, which praises his community focus, strong business acumen, and commitment to patient care. Last but certainly not least, Landys Chemist in North-West London who were awarded with the Independent Pharmacy of the Year Award for their sharp focus on sustainability and plastic free approach to pharmacy.

 

Alliance Healthcare would like to congratulate our remarkable Alphega Pharmacy members for their outstanding work and commitment to community pharmacy.  

 

Jackie Lewis
Lewis Pharmacy Team

 

SUB-TYPE: CLASS 3 RECALL

CLASS 3 RECALL - METHADONE TAB 5MG (PHYSEPTONE 5MG TABLETS)

Martindale Pharma is recalling the below batch of Methadone 5mg tablets as a precautionary measure due to the discolouration of the PVdC film in a small number of blister pockets

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-martindale-pharma-an-ethypharm-group-company-methadone-5mg-tablets-slash-physeptone-5mg-tablets-el-21-a-slash-31?utm_medium=email&utm_campaign=govuk-notifications&utm_source=c480fd76-d520-4a64-9570-f410b38c7b35&utm_content=immediately   

Pip code

Product description

Supplier

Batch numbers

8032484

METHADONE TAB 5MG (PHYSEPTONE 5MG TABLETS)

MARTINDALE PHARMA

128319

This product is a Schedule 2 Controlled Drug, so please use the Returns Portal for any recalled stock you may need to return to ensure there is authorization to return. When you are completing the portal if you are returning a split pack Please include exact number of tablets you are returning. If you are unable to use the Returns Portal please call Customer Services for assistance.

Further Information

 

For more information please contact:

 

Customer Services for stock control enquiries: Licensed@ethypharm.com

 

or for Medical Information enquiries: medinfo@martindalepharma.co.uk

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

 

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

 

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 3 RECALL

CLASS 3 RECALL - METHADONE TAB 5MG (PHYSEPTONE 5MG TABLETS)

Martindale Pharma is recalling the below batch of Methadone 5mg tablets as a precautionary measure due to the discolouration of the PVdC film in a small number of blister pockets

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-martindale-pharma-an-ethypharm-group-company-methadone-5mg-tablets-slash-physeptone-5mg-tablets-el-21-a-slash-31?utm_medium=email&utm_campaign=govuk-notifications&utm_source=c480fd76-d520-4a64-9570-f410b38c7b35&utm_content=immediately   

Pip code

Product description

Supplier

Batch numbers

8032484

METHADONE TAB 5MG (PHYSEPTONE 5MG TABLETS)

MARTINDALE PHARMA

128319

 

Further Information

 

For more information please contact:

 

Customer Services for stock control enquiries: Licensed@ethypharm.com

 

or for Medical Information enquiries: medinfo@martindalepharma.co.uk

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

 

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

 

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

CLASS 2 RECALL - IKERVIS EYE DROPS 0.1% & VERKAZIA 0.1% EYE DROPS UD

SANTEN Oy (trading as Santen UK Limited) are recalling the below batches of products as a precautionary measure due to detection of particles/crystals of the active pharmaceutical ingredient ciclosporin. These particles have been detected following microscopic evaluation during stability monitoring

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-santen-oy-trading-as-santen-uk-limited-and-parallel-distributor-ikervis-1-mg-slash-ml-eye-drops-emulsion-and-verkazia-1-mg-slash-ml-eye-drops-emulsion-el-21-a-slash-30?utm_medium=email&utm_campaign=govuk-notifications&utm_source=ed7060ba-57ef-42eb-89b1-ac5b77c8be8a&utm_content=immediately  

 

Pip code

Product Description

Supplier

Batch Numbers

3986395

IKERVIS EYE DROPS 0.1%

SANTEN UK LIMITED

8K38Q

4L41F

8L28C

4087276

VERKAZIA 0.1% EYE DROPS UD

SANTEN UK LIMITED

1L14P

4L40H

6L04J

N/A

PI IKERVIS EYE DROPS 0.1%

ORIFARM A/S

6L03F

 

Alliance do not stock the above products so we will not be accepting Customer returns on this recall.

 

 

Further Information

 

Santen UK Limited

For more information, please contact +44 (0)1727 615 110 or email enquiries@santen.co.uk

 

For medical information queries, please contact 0345 075 4863 or email medinfo@santen.co.uk

 

For supply queries, please contact AAH Customer services at 0344 561 8899

 

Orifarm A/S

For all enquiries please contact:

 

Paul Tobin (Responsible Person) on 07583577513 or email at paul.tobin@orifarm.com

 

Steven Cross (UK Parallel Import Sales Manager) on 07498975920 or email at steven.cross@orifarm.com

 

 

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 Drug Caution in use - SLENYTO 1 MG AND 5MG PROLONGED RELEASE TABLETS

Flynn Pharma Ltd, distributors of Slenyto 1 mg and 5mg prolonged release tablets would like to notify you of an error with the patient information leaflets (PILs) that have been packaged in the below batches of products. These were an older version of the PIL which did not include the most up to date safety information

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-slenyto-1-mg-and-5mg-prolonged-release-tablets-distributed-by-flynn-pharma-ltd-el-21-a-slash-29?utm_medium=email&utm_campaign=govuk-notifications&utm_source=918a7eae-bd86-4833-899a-5114d92b0980&utm_content=immediately      

 

Pip code

Product description

Supplier

Batch Numbers

4102091

SLENYTO 1MG PROLONGED RELEASE TAB

FLYNN PHARMA LTD

1049309A

1049310

1049311

1049312

1051815

80419B

90287

10175A

10186

4102083

SLENYTO 5MG PROLONGED RELEASE TAB

FLYNN PHARMA LTD

00130

00409C

10058

 

 

Alliance healthcare do not stock this product therefore we are not accepting stock returns.

 

Further Information

 

For more information, medical information queries or replacement PIL enquiries, please contact:

 

Flynn Pharma Ltd Medical Information Department on 01438 727822, email – medinfo@flynnpharma.com.

 

For stock control queries, please contact: Flynn Pharma Ltd on 01438 727822

 

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: COMPANY-LED RECALL

COMPANY-LED DRUG ALERT - DOTAREM SOLUTION FOR INJECTION (10ML VIAL)

Guerbet Laboratories Ltd is recalling the below batches of Dotarem 10ml vials, due to the potential risk of a sterility break, based on the evidence of external leaks of the solution (dry product on the external surface of the vials)

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/company-led-medicines-recall-dotarem-solution-for-injection-10ml-vial-pl-12308-slash-0016?utm_medium=email&utm_campaign=govuk-notifications&utm_source=6e2cf2cc-77cb-4717-a214-e7df6d710c9c&utm_content=immediately        

Pip code

Product description

Supplier

Batch numbers

ALLIANCE DO NOT STOCK

DOTAREM SOLUTION FOR INJECTION (10ML VIAL)

GUERBET LABORATORIES LTD

21GD006B04

21GD006C01

 

Alliance do not stock this product and therefore we are not accepting stock returns.

 

Company Contact for medical information enquiries

 

For medical information enquiries, please contact James Bradley (GDP RP):

 

james.bradley@guerbet.com

 

Company Contact for stock enquiries

 

For stock information enquiries,

 

UK Customer Services

 

uk.sales@guerbet.com

 

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

CLASS 2 RECALL - COLD & FLU RELIEF CAPSULES (GSL) – VARIOUS LIVERIES

Perrigo are recalling the below batches of Cold & Flu Relief Capsules (GSL) – Various Liveries, due to an error on the leaflet and carton for the products as noted above. The leaflet and carton incorrectly states that for Adults, the elderly and children 12 years and over, the dose should be 2 capsules every 4 to 6 hours as required, up to a maximum of 12 capsules in any 24 hour period. The leaflet and carton dosage instructions are those which were in use prior to the paediatric paracetamol posology update implemented by the MHRA

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-cold-and-flu-relief-capsules-gsl-various-liveries-wrafton-laboratories-limited-trading-as-perrigo-el-21-a-slash-28?utm_medium=email&utm_campaign=govuk-notifications&utm_source=f44f6fc5-9c7f-4cc3-b3ab-df07db229afc&utm_content=immediately   

 

Pip code

Product Description

Supplier

Batch Numbers

ALLIANCE DO NOT STOCK

WILKO NON-DROWSY DECONGESTANT WITH PARACETAMOL

WRAFTON LABORATORIES LIMITED (TRADING AS PERRIGO)

9CW0032

9DW0077

9GW0048

9LW0165

0DW0072

0EW0108

0FW0086

ALLIANCE DO NOT STOCK

SPAR COLD RELIEF CAPSULES

WRAFTON LABORATORIES LIMITED (TRADING AS PERRIGO)

9CW0030

9EW0009

9MW0018

0AW0013

0DW0071

0FW0081

ALLIANCE DO NOT STOCK

ESSENTIAL WAITROSE COLD & FLU RELIEF CAPSULES

WRAFTON LABORATORIES LIMITED (TRADING AS PERRIGO)

9KW0128

0DW0092

0GW0144

ALLIANCE DO NOT STOCK

ALDI HEALTH ESSENTIALS COLD RELIEF CAPSULES

WRAFTON LABORATORIES LIMITED (TRADING AS PERRIGO)

9FW0041

9GW0049

9HW0149

0CW0186

0GW0121

0JW0055

ALLIANCE DO NOT STOCK

ASDA COLD RELIEF CAPSULES

WRAFTON LABORATORIES LIMITED (TRADING AS PERRIGO)

9FW0065

9GW0051

9JW0005

0AW0027

0BW0098

0CW0139

0DW0093

0FW0083

0KW0008

8012114

SUPERDRUG COLD RELIEF CAPSULES

WRAFTON LABORATORIES LIMITED (TRADING AS PERRIGO)

9CW0031

9EW0069

9HW0087

0AW0111

0CW0184

0EW0109

8012163

SUPERDRUG NON-DROWSY DECONGESTANT WITH PARACETAMOL

WRAFTON LABORATORIES LIMITED (TRADING AS PERRIGO)

9EW0112

0AW0016

0DW0073

ALLIANCE DO NOT STOCK

SAINSBURY’S HEALTHCARE COLD RELIEF CAPSULES

WRAFTON LABORATORIES LIMITED (TRADING AS PERRIGO)

9DW0138

9JW0006

9KW0126

0BW0096

0DW0117

1AW0059

ALLIANCE DO NOT STOCK

SAINSBURY’S HEALTHCARE SINUS DUAL RELIEF CAPSULES

WRAFTON LABORATORIES LIMITED (TRADING AS PERRIGO)

9DW0075

9HW0014

9KW0127

0AW0150

0FW0084

1DW0053

ALLIANCE DO NOT STOCK

LLOYDS COLD RELIEF CAPSULES

WRAFTON LABORATORIES LIMITED (TRADING AS PERRIGO)

9GW0050

9MW0015

0GW0143

ALLIANCE DO NOT STOCK

WM MORRISON COLD RELIEF CAPSULES

WRAFTON LABORATORIES LIMITED (TRADING AS PERRIGO)

9DW0076

9HW0150

0AW0151

0EW0107

0KW0007

1JW0030

ALLIANCE DO NOT STOCK

BOOTS COLD & FLU RELIEF CAPSULES

WRAFTON LABORATORIES LIMITED (TRADING AS PERRIGO)

9EW0113

9FW0040

9HW0026

9HW0152

9MW0017

0AW0152

0CW0183

0DW0094

0FW0087R

ALLIANCE DO NOT STOCK

BOOTS BLOCKED NOSE & HEADACHE RELIEF CAPSULES

WRAFTON LABORATORIES LIMITED (TRADING AS PERRIGO)

9FW0039

9HW0027

9KW0125

0AW0015

0CW0185

0DW0091

1JW0022

ALLIANCE DO NOT STOCK

TESCO COLD RELIEF CAPSULES

WRAFTON LABORATORIES LIMITED (TRADING AS PERRIGO)

9BW0110

9EW0021

9HW0011

9KW0123

9MW0016

0AW0014

0BW0097

0CW0141

0DW0090

0FW0088

0KW0006

3492758

GALPHARM COLD RELIEF CAPSULES

WRAFTON LABORATORIES LIMITED (TRADING AS PERRIGO)

9FW0064

9HW0025

9HW0151

9KW0124

9LW0164

0AW0153

0CW0140

0DW0116

0FW0085

0GW0066

0KW0066

 

 

Further Information

 

For more information, please contact: Perrigo Customer Services Team on 0203 598 9603 or UKLOCustomerService@perrigo.com

 

For stock control queries, please contact: Perrigo Service Team on 01226 704711 or customerservice@perrigouk.com

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

 

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

 

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE:

11.11.2021

Alliance Healthcare partners with Novo Nordisk for the launch of PenCycle; the circular recycling initiative

 

Alliance Healthcare UK is delighted to collaborate with Novo Nordisk to help reduce plastic pen devices entering UK landfills by up to 1.1 million in the next year.

 

Novo Nordisk, a global healthcare company specialising in treatments for people living with diabetes, obesity, and rare blood and endocrine disorders, has launched PenCycle; the circular recycling initiative for pre-filled diabetes and weight management pens. As a partner organisation, Alliance Healthcare will be delivering all the materials needed to recycle the pre-filled injection pen devices, including a blue PenCycle Recycling Bin, PenCycle Return Boxes and other support materials to Community pharmacy. These materials are being provided completely free of charge by Novo Nordisk. 

 

pl

 

A first-of-its-kind in the UK, the PenCycle Pilot has launched across Greater Manchester, Leicestershire & Rutland, and Greater Glasgow and Clyde, ahead of a planned national roll-out next year. Selected pharmacies in these areas have been invited to participate to show their support towards the environmental target, and upon sign up of the scheme, will play a big role in helping to reduce waste and advance the sustainability agenda of community pharmacy.

 

Skills in Healthcare has led participation in the project on behalf of Alliance Healthcare, from initial discussions with Novo Nordisk to the official launch which happened on 1st November. Skills in Healthcare will now support pharmacy engagement and on boarding of pharmacies to the scheme.

 

Paul Fowler, Head of Skills in Healthcare, presented at the launch event and said: “We are delighted to be partnered with Novo Nordisk, supporting the design and delivery of the PenCycle Recycling Pilot within a pharmacy setting. The process has been designed to be simple to manage and allows a pharmacy to participate by using all the systems and processes they are already familiar with. It provides their patients with a new pharmacy return option and supports them to recycle their Novo Nordisk Insulin pens. I hope all the pharmacies in the pilot areas will participate and help make PenCycle a real success story. “

 

As a central point of care, community pharmacies will be key to the success of this forward-thinking initiative, and Alliance Healthcare are delighted to play a part of it.

 

Pharmacies located in the relevant pilot areas are encouraged to join the scheme by visiting: https://www.alliance-healthcare.co.uk/pencycle.

 

For more information, you can contact the Skills in Healthcare PenCycle team at: PenCycle@skills-in-healthcare.co.uk

 

pn pen

 

About Skills in Healthcare

Skills in Healthcare is a contract sales and marketing business that provides customers with flexible and cost-effective solutions to realise retail pharmacy potential. With over 70 years’ experience in retail pharmacy, Skills in Healthcare provides a wide range of services including dynamic sales support, training, consulting, call centre and branding support.

To find out more visit: https://www.skills-in-healthcare.co.uk/

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 Drug Caution in use - MITOCIN (MITOMYCIN) 20MG POWDER FOR SOLUTION FOR INJECTION/INFUSION

Vygoris Limited has informed the MHRA that some vials of Mitocin 20mg powder for solution for injection/infusion or intravesical use may contain subvisible particles above the current specifications after reconstitution (>10µm: NMT 6000/vial), initially identified during stability studies. Vygoris Limited has confirmed that a single-use filtration device called the Millex® HV (0.45 μm/PVDF) - Syringe Filter will be included in each delivery of the product

 

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-vygoris-limited-mitocin-mitomycin-20mg-powder-for-solution-for-injection-slash-infusion-or-intravesical-use-el-21-a-slash-27?utm_medium=email&utm_campaign=govuk-notifications&utm_source=23f29568-2411-48f9-bc43-7b69aed25c18&utm_content=immediately                  

Pip code

Product description

Supplier

Batch numbers

ALLIANCE DO NOT STOCK

MITOCIN (MITOMYCIN) 20MG POWDER FOR SOLUTION FOR INJECTION/INFUSION

VYGORIS LIMITED

0-20071AB

0-20081AB

0-20102AB

0-20112AA

0-20042AA

0-20013AD

 

This is a caution in use only we are not accepting stock returns.

 

Further Information

 

For medical information queries, please contact:

 

Lucy Owen,

 

ProductLifeGroup

 

Tel: +44 (0) 1223 402660

 

Email: lowen@productlife-group.com

 

For more information or stock control queries, please contact:

 

Hussain Tahan

 

Vygoris Ltd

 

Tel: 020 3865 1682

 

Email: qualitylimited@vygoris.com

 

If you have any questions, then please contact your local Service Centre Customer Services team